Un argentino, detrás del descubrimiento que podría marcar un antes y un después en el tratamiento contra el Alzheimer
El científico Oscar López, director del Centro de Investigación de la Enfermedad de Alzheimer de la Universidad de Pittsburgh, habló con Infobae y explicó los detalles de la investigación
/cloudfront-us-east-1.images.arcpublishing.com/infobae/OK2L65VVKFCJ3F5XBHP6734EQI.jpg)
/s3.amazonaws.com/arc-wordpress-client-uploads/infobae-wp/wp-content/uploads/2018/11/01101342/paciente-cuadriplejico.jpg)
/s3.amazonaws.com/arc-wordpress-client-uploads/infobae-wp/wp-content/uploads/2018/04/18133929/Cerebro-Alzheimer-22.jpg)
/s3.amazonaws.com/arc-wordpress-client-uploads/infobae-wp/wp-content/uploads/2018/06/28091317/robot-asimo-2.jpg)
/s3.amazonaws.com/arc-wordpress-client-uploads/infobae-wp/wp-content/uploads/2017/07/10191223/biofarmaceutica.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/FDZPP2U4O6CISEWJFHUDIKIMYM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/XNS3TQ6LJKLPBUIBJ7L3BBOY3M.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/4QLGOYXXHFFURGZ55THHNNIUQA.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/375NNBH7SBDIPGZWC2B3E4DM74.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/54A72K3BERCGTJL5DUDHTFRQ3A.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/K22XSWTVKVGWNDOHD675DU5SSE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/FANDSOBBE3QU2E5ZFIH55U4UXE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/HZAHXGPDUBHBRB5AER6PFYBEH4.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/ZRHTLCQSI5DUVPMWJAVNDFL57M.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/RNPFXPREQNBDNAIPOAHLUY4KEY.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/O2ZWL7LZAGKFBL5GMMAXIWK34M.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/QB4R6NKFBF4DFJLZB7CJYFYMRM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/VJSUQUE5VJAATIAHHWLZ5ATPPM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/PZZWTI6EPTGGR4WGQR4K2NNJHE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/4GEXAW4UGA3HBL2GQHXS6TUVLA.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/FFUBGKS7MJBRBGFPH4BXYZDWYE.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/JSWBGPYQSFGNNOMIMH4MWXHG2Q.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/L53WZHSOVZD3NNCBQDTQ6TWKJM.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/ZRHTLCQSI5DUVPMWJAVNDFL57M.jpg)
/cloudfront-us-east-1.images.arcpublishing.com/infobae/375NNBH7SBDIPGZWC2B3E4DM74.jpg)